Blackmores' Launch of Nutriventia's TurmXTRA™ Based Range Validates Science of Concentrated Turmeric Ingredient

June 11, 2024 10:00 PM AEST | By Cision

Blackmores' Launch of Nutriventia's TurmXTRA™ Based Range Validates Science of Concentrated Turmeric Ingredient — Image source: Kalkine Media

Recent News

EU targets Boeing with potential tariffs amid stalled U.S. talks- FT

How Did the Federal Court Judgment Impact ASX 200 and ASX Financials T...

ASX 200 Update: Key Stock Movements and Market Insights – 7 May 2025

Yari Minerals: ASX 200 Coal Acquisition Enhances Bowen Basin Assets

Blackmores' introduction of a range of products containing Nutriventia's TurmXTRA^™ validates its science, safety, and efficacy

MUMBAI, India, June 11, 2024 /PRNewswire/ -- Nutriventia Limited, a leading innovator of clinically proven, tech-driven clean ingredients for the health and wellness industry, proudly announces a significant milestone with the launch of one of its flagship branded ingredients, TurmXTRA^™. This marks a pivotal moment in the validation of Nutriventia's commitment to science and efficacy.

Nutriventia

TurmXTRA is a clinically proven ingredient for its effectiveness at the low dosage of 250mg curcuminoids and is award-winning for supporting joint and muscle health. TurmXTRA has recently been accepted into a range of products by Blackmores, underscoring the credibility and effectiveness of this unique low-dose turmeric extract. The acceptance of TurmXTRA into Blackmores' product line demonstrates the scientific rigor and potential to deliver tangible health benefits.

Vishal Shah, Nutriventia's co-founder and executive director, commented, "TurmXTRA's inclusion in Blackmores' products validates our philosophy of delivering high-quality, clinically proven ingredients to our customers, especially a brand with high standards for excellent such as Blackmores."

Kazim Vakil, Director at VILCO PTY, Nutriventia's exclusive distributor for Australia & New Zealand, added, "The acceptance of TurmXTRA by Blackmores is a clear validation of its efficacy and safety profile. We are proud to offer our customers a genuine low-dose turmeric extract with proven clinical benefits, setting a new standard in the industry."

Nutriventia and VILCO recently showcased their partnership at the CMA (Complementary Medicines Australia), The Science of Self Care Innovation Day, where TurmXTRA^™ and ashwanova^™, the flagship brands of Nutriventia, were key sponsors. This provided an ideal platform to demonstrate the success of TurmXTRA and highlight the differentiation of Nutriventia's products with others on the market.

Nutriventia made a remarkable impact at the CMA Innovation Day 2024, held under the theme "The Science of Self Care" on May 7, 2024. The event saw an outstanding turnout, underscoring the growing interest in innovative health solutions. A key highlight of the event was the exclusive launch of ashwanova^™ in Australia and New Zealand, while continuing to showcase our well-established branded ingredient, Prolanza^™, in all other regions. This trademarked branded ingredient represents a significant step forward in stress management, offering long-acting ashwagandha for all-day stress support. ashwanova^™ is poised to set new standards in the wellness industry, providing our customers with a reliable solution to manage daily stress.

In addition to ashwanova^™, Nutriventia revealed groundbreaking new research on TurmXTRA^™, a proprietary water-dispersible turmeric extract. The human clinical study showcased TurmXTRA's superior bioavailability, demonstrating bioequivalence from a single 250 mg dose when compared to a leading branded turmeric extract with piperine, which is commonly consumed in three 500 mg doses. This finding highlights and justifies TurmXTRA's efficiency and potency at a 250mg once daily dose which is also corroborated from the earlier clinical trials which showed benefits in healthy human subjects, positioning it as ingredient of choice for turmeric supplementation in all applications.

Nutriventia's presence at the CMA Innovation Day 2024 exemplifies its commitment to advancing the science of self-care and providing top-tier nutraceutical solutions.

ABOUT NUTRIVENTIA
Nutriventia Limited, based in Mumbai, India, is a leader in combining the benefits and assurance of both science and nature in premium functional ingredients for health and wellness. Its inception can be traced to almost four decades ago, when two scientists with deep-rooted knowledge in medical sciences, ventured out to develop solutions that were an improvement on generic products becoming the pioneers of NDDS products in India. Through the use of proprietary and patented processes, Nutriventia has addressed issues and concerns in manufacturing, formulation, and clinical research, resulting in ingredients that are superior in quality and efficacy. Nutriventia's dedication to innovation and improving ingredients is unparalleled, making them a preferred partner in the supplement industry. Their commitment to combining science and nature in the creation of high-quality, functional ingredients is a testament to their mission to improve health and wellness for consumers worldwide.

Media Contact:
Pamela B. Stewart
Essenza Communications, Inc.
[email protected]
303.570.1678

Logo - https://mma.prnasia.com/media2/2434452/nutriventia_black_logo_2x__1.jpg?p=medium600

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.